EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access

Short-Term Effects of Nonnutritive Sweetener (Sucralose and Saccharin) Consumption on Glycemic Control and Gut Microbiota in Patients With Type 2 Diabetes: Protocol for a Double-Blind, Randomized, Placebo-Controlled, Crossover Trial

Huey Shin Tan iD, Harvinder Kaur Gilcharan Singh iD, Vanitha Mariappan iD, Nor Aini Jamil iD, Suhaili Naim Mustapa iD, Snigdha Misra iD

JMIR Research Protocols · 2025

DOI: 10.2196/82695 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Huey Shin Tan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Community Health Studies (ReaCH), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Diabetes Mellitus, Type 2, Saccharin, Sucrose. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nonnutritive sweeteners (NNSs) are widely used as sugar substitutes to help individuals with diabetes manage glycemic control. However, emerging evidence suggests that even low doses of NNSs, such as saccharin and sucralose, may adversely affect metabolic health by impairing glycemic regulation, potentially through alterations in the gut microbiota. In Malaysia, where gut microbiome research is still limited, particularly among individuals with type 2 diabetes mellitus (T2DM), further investigation is warranted to inform safe and evidence-based use of NNSs.

Objective

This study aims to evaluate the short-term effects of saccharin and sucralose consumption on glycemic control and gut microbiota composition in adults with T2DM.

Methods

This is a double-blind, randomized, placebo-controlled, crossover trial. A total of 33 adults with T2DM will consume sucralose (5 mg/kg body weight), saccharin (2 mg/kg body weight), or a placebo (calcium carbonate) in capsule form daily for 7 days per intervention arm, with a 4-week washout period. Data collection will include anthropometric measurements, biochemical assessments for glycemic control, dietary records, physical activity levels, and stool samples. The homeostatic model assessment for insulin resistance will be used to assess insulin sensitivity, while 16S rRNA V3-V4 region sequencing will be conducted to profile gut microbiota composition.

Results

Recruitment is planned to begin in January 2026 and is expected to conclude by September 2026, with study completion anticipated by March 2027. As of December 2025, no participants have been enrolled.

Conclusions

This trial will contribute novel insights into the effects of short-term NNS consumption on glycemic control and gut microbiota composition in individuals with T2DM. These findings may support evidence-based recommendations for NNS use in diabetes management and enhance understanding of microbiome-diet interactions in an ethnically diverse Asian population. Trial Registration ClinicalTrials.gov NCT07124585; https://clinicaltrials.gov/study/NCT07124585 International Registered Report Identifier (IRRID) PRR1-10.2196/82695

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDiabetes Mellitus, Type 2SaccharinSucroseGlycemic ControlNon-Nutritive SweetenersSweetening AgentsHumansDouble-Blind MethodCross-Over StudiesAdultMaleFemaleMiddle AgedBlood GlucoseRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

artificial sweetenerglycemic controlgut microbiotanonnutritive sweetenersaccharinsucralosetype 2 diabetes mellitus

Substanzen

trichlorosucroseSaccharinSucroseNon-Nutritive SweetenersBlood GlucoseSweetening Agents

Autor:innen und Institutionen

  • Centre for Community Health Studies (ReaCH), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
  • Center for Toxicology and Health Risk Studies (CORE), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
  • Klinik Kesihatan Setapak, Kuala Lumpur, Malaysia.
  • Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Kuala Lumpur, Malaysia.

ORCID-Profile: Huey Shin Tan, Harvinder Kaur Gilcharan Singh, Vanitha Mariappan, Nor Aini Jamil, Suhaili Naim Mustapa, Snigdha Misra

Zitieren

APA

Tan, H. S., Gilcharan Singh, H. K., Mariappan, V., Jamil, N. A., Mustapa, S. N., & Misra, S. (2025). Short-Term Effects of Nonnutritive Sweetener (Sucralose and Saccharin) Consumption on Glycemic Control and Gut Microbiota in Patients With Type 2 Diabetes: Protocol for a Double-Blind, Randomized, Placebo-Controlled, Crossover Trial. JMIR Research Protocols. https://doi.org/10.2196/82695

Vancouver

Tan HS, Gilcharan Singh HK, Mariappan V, Jamil NA, Mustapa SN, Misra S. Short-Term Effects of Nonnutritive Sweetener (Sucralose and Saccharin) Consumption on Glycemic Control and Gut Microbiota in Patients With Type 2 Diabetes: Protocol for a Double-Blind, Randomized, Placebo-Controlled, Crossover Trial. JMIR Research Protocols. 2025. doi:10.2196/82695

BibTeX
@article{Tan2025,
  author = {Tan, Huey Shin and Gilcharan Singh, Harvinder Kaur and Mariappan, Vanitha and Jamil, Nor Aini and Mustapa, Suhaili Naim and Misra, Snigdha},
  title = {Short-Term Effects of Nonnutritive Sweetener (Sucralose and Saccharin) Consumption on Glycemic Control and Gut Microbiota in Patients With Type 2 Diabetes: Protocol for a Double-Blind, Randomized, Placebo-Controlled, Crossover Trial},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/82695}
}
Kostenlos starten →